2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Antibody Deficiency Syndrome in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glassford, J | 1 |
| Soeiro, I | 1 |
| Skarell, SM | 1 |
| Banerji, L | 1 |
| Holman, M | 1 |
| Klaus, GG | 1 |
| Kadowaki, T | 1 |
| Koyasu, S | 1 |
| Lam, EW | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Topics: Adaptor Proteins, Signal Transducing; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Antibodi | 2003 |